RiceBran Technologies (NASDAQ:RIBT) shares fell to a low of $1.04 before closing at $1.06. Intraday shares traded counted 0.4 million, which was 90.91% higher than its 30-day average trading volume of 4.38M. RIBT’s previous close was $1.07 while the outstanding shares total 45.63M. The firm has a beta of 0.37. The stock’s Relative Strength Index (RSI) is 58.63, with weekly volatility at 5.11% and ATR at 0.09. The RIBT stock’s 52-week price range has touched low of $0.37 and a $1.83 high. The stock traded lower over the last trading session, losing -0.93% on 05/28/21.
Investors have identified the Packaged Foods company RiceBran Technologies as an interesting stock but before investments are made there, an in-depth look at its trading activities will have to be conducted. The share is trading with a market value of around $48.60 million, the company now has both obstacles and catalysts that affect them and they came from their mode of operations. With the company affected by events currently, it is a perfect time to analyze the numbers behind the firm in order to come up with a rather realistic picture of what this stock is.
RiceBran Technologies (RIBT) Fundamentals that are to be considered.
When analyzing a stock, the first fundamental thing to take into account is the balance sheet. How healthy the balance sheet of a company is will determine if the company will be able to carry out all its financial and non-financial obligations and also keep the faith of its investors. For RIBT, the company has in raw cash 5.42 million on their books with 0.6 million currently as liabilities. How the trend is over time is what investors should be concerned about. The company has a healthy balance sheet as their debt profile has been on an incline. In terms of their assets, the company currently has 12.26 million total, with 7.35 million as their total liabilities.
RIBT were able to record -0.33 million as free cash flow during the 08/12/2021 quarter of the year, this saw their quarterly net cash flow reduce by 0.15 million. In cash movements, the company had a total of 1000.0 as operating cash flow.
Potential earnings growth for RiceBran Technologies (RIBT)
In order to determine the future investment potential for this stock, we will have to analyze key trends that affect it. During the 08/12/2021 quarter of the year, RiceBran Technologies recorded a total of 8.61 million in revenue. This figure implies that they witnessed a quarterly year/year change in their earnings with 3.2% coming in sequential stages and their sales for the 08/12/2021 quarter increasing by 20.91%.
What matters though is how it ends. When the core data for the company is broken down, then the stock sounds interesting. The company spent 7.93 million trying to sell their products during the last quarter, with the result yielding a gross income of 0.67 million. This allows shareholders to hold on to 45.63M with the recently reported earning now reading 0.01 cents per share. This is a figure that compared to analyst’s prediction for their 08/12/2021 (-0.38 cents a share).
Is the stock of RIBT attractive?
In related news, Director, Rosenthal Brent David bought 11,779 shares of the company’s stock in a transaction that recorded on May 06. The purchase was performed at an average price of 0.92, for a total value of 10,837. As the purchase deal closes, the Director, Gendason Ari David now bought 5,000 shares of the company’s stock, valued at 4,800. Also, Director, Gendason Ari David bought 5,000 shares of the company’s stock in a deal that was recorded on Mar 23. The shares were cost at an average price of 1.02 per share, with a total market value of 5,095. Following this completion of disposal, the Director, Gendason Ari David now holds 1,460 shares of the company’s stock, valued at 1,124. In the last 6 months, insiders have changed their ownership in shares of company stock by 1.60%.
1 out of 1 analysts covering the stock have rated it a Buy, while 0 have maintained a Hold recommendation on RiceBran Technologies. 0 analysts has assigned a Sell rating on the RIBT stock. The 12-month mean consensus price target for the company’s shares has been set at $1.50.